concord ventures LLC

111 8th avenue, suite 1500
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 12, 2013

NYS DOS ID#
4430037

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - CONCORD VENTURES LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • A Handmaid’s Tale of Protest
    By CHRISTINE HAUSER - Friday Jun 30, 2017

    In state capitals and street protests, women’s rights activists have been wearing red robes and white bonnets based on “The Handmaid's Tale,” the 1985 novel that is now a series on Hulu.

    Source: NYT > Home Page
  • 100,000 Companies Now Using Concord for Contract Management
    By Business Wire - Tuesday Sep 12, 2017

    Concord, a leading contract management platform, now has 100,000 companies online and managing their contracts. The number of companies on the platform grew 400% in the 19 months between Concord's seed funding and Series A, and has continued...

    Source: VentureBeat
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy New York